TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells. (2015)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/onc.2014.156
PubMed Identifier: 24909167
Publication URI: http://europepmc.org/abstract/MED/24909167
Type: Journal Article/Review
Volume: 34
Parent Publication: Oncogene
Issue: 16
ISSN: 0950-9232